🔎 Trials Near Me

Home › Kanser sa Dugo › Georgia › Atlanta

Pag-aaral pangklinika para sa Kanser sa Dugo sa Atlanta, GA

Isang pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Atlanta. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Atlanta VA Medical Center, Decatur · 6 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Nagre-recruitPhase 2
  • Emory University Winship Cancer Institute, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04634552

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Nagre-recruitPhase 2
  • Winship Cancer Institute - Emory University, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Nagre-recruitPhase 1
  • Emory Winship Cancer Institute, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06823167

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Nagre-recruitPhase 2
  • Northside Hospital, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06665100

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Nagre-recruitPhase 1/2
  • Emory Winship Cancer Institute, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT04068597

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Nagre-recruitObservasyonal na pag-aaral
  • Caitlin Guzowski, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT05417971

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Nagre-recruitPhase 1/2
  • Emory University Hospital, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2025 · NCT06119685

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1
  • Children's Healthcare of Atlanta, Emory University, Atlanta
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa Kanser sa Dugo sa ibang lungsod

Iba pang pag-aaral sa Atlanta

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.